Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Chengdu Zenitar Biomedical Technology Co., Ltd
M.D. Anderson Cancer Center
City of Hope Medical Center
University College, London
Northwestern University